decorative image
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
decorative image
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

n/a Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.

Weekly NIH Funding Opportunities and Notices
September 29, 2017

General Notices

Funding Opportunities

  • Addressing Chronic Wound Trajectories Through Social Genomics Research (R01 Clinical Trial Optional)
    (PA-17-492)
    National Institute of Nursing Research
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Addressing Chronic Wound Trajectories Through Social Genomics Research (R21 Clinical Trial Optional)
    (PA-17-493)
    National Institute of Nursing Research
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional)
    (PA-17-495)
    National Cancer Institute
    Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Research to Improve Native American Health (R21 Clinical Trial Optional)
    (PAR-17-464)
    National Cancer Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    Office of Behavioral and Social Sciences Research
    National Institute on Minority Health and Health Disparities
    Application Receipt Date(s): May 14, 2018; May 14, 2019; August 14, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R21 Clinical Trial Optional)
    (PAR-17-490)
    National Institute of Nursing Research
    National Institute on Minority Health and Health Disparities
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R01 Clinical Trial Optional)
    (PAR-17-491)
    National Institute of Nursing Research
    National Institute on Minority Health and Health Disparities
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • NCI Outstanding Investigator Award (R35)
    (PAR-17-494)
    National Cancer Institute
    Application Receipt Date(s): November 28, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
    (PAR-17-496)
    National Cancer Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    National Institute of Nursing Research
    Office of Behavioral and Social Sciences Research
    National Institute on Minority Health and Health Disparities
    Application Receipt Date(s): May 14, 2018; May 14, 2019; August 14, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Continuation of the AMP-AD Target Discovery and Preclinical Validation Consortium (U01 Clinical Trial Optional)
    (RFA-AG-18-013)
    National Institute on Aging
    Application Receipt Date(s): February 20, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Limited Competition: Data Coordinating Center for the Accelerating Medicines Partnership Target Discovery and Preclinical Validation Consortium AMP-AD DCC (U24 Clinical Trial Not Allowed)
    (RFA-AG-18-014)
    National Institute on Aging
    Application Receipt Date(s): February 20, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this funding opportunity announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Pediatric Immunotherapy Translational Science Network (PI-TSN)(U54)
    (RFA-CA-17-050)
    National Cancer Institute
    Application Receipt Date(s): December 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Pediatric Immunotherapy Translational Science Network (PI-TSN)(U01)
    (RFA-CA-17-051)
    National Cancer Institute
    Application Receipt Date(s): December 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability (U01)
    (RFA-CA-17-052)
    National Cancer Institute
    Application Receipt Date(s): January 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Diabetic Foot Consortium - Clinical Research Units (U01)
    (RFA-DK-17-014)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): January 23, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Lymphatics in Health and Disease in the Digestive System (R01 - Clinical Trials Not Allowed)
    (RFA-DK-17-016)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): February 2, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Opioid Use Disorder in Pregnancy (R01)
    (RFA-HD-18-036)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    Application Receipt Date(s): December 13, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00)
    (RFA-NS-18-007)
    National Institute of Neurological Disorders and Stroke
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Aging
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Eye Institute
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute of Mental Health
    National Institute of Nursing Research
    National Center for Complementary and Integrative Health
    National Institute of Biomedical Imaging and Bioengineering
    Office of Behavioral and Social Sciences Research
    NIH Blueprint for Neuroscience Research
    Application Receipt Date(s): December 13, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01)
    (RFA-NS-18-008)
    National Institute of Neurological Disorders and Stroke
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Aging
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Eye Institute
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute of Mental Health
    National Center for Complementary and Integrative Health
    National Institute of Biomedical Imaging and Bioengineering
    Office of Research on Women's Health
    Office of Behavioral and Social Sciences Research
    Application Receipt Date(s): December 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.